Glazkova N B, Aref'eva T I, Antonova O A, Krasnikova T L
Cardiology Research Centre, 121552, Moscow, 3rd Cherepkovskaya St., 15a, Russia.
Ross Fiziol Zh Im I M Sechenova. 2003 Jan;89(1):43-51.
Monocyte chemoattractant protein (MCP-1) is a major chemoattractant for monocytes and T-lymphocytes although it can cause migration of the HUVECs. We used monocytic cell line THP-1, monocytes of human peripheral blood, and HUVECs to study MCP-1 receptor-mediated cell migration. We showed that THP-1 and the monocytes chemotaxis was decreased in presence of specific inhibitors of p 38 MAP-kinase. Furthermore, it was almost completely diminished by inhibitor of tyrosine kinases. In contrast, MCP-1-stimulated migration of HUVECs was abrogated by specific inhibitor of ERK1/2 MAP-kinases and, to a lesser extent, by blocking tyrosine kinases. These results suggest that intracellular signal pathways activated by MCP-1 in monocytes and HUVECs, are distinct.
单核细胞趋化蛋白-1(MCP-1)是单核细胞和T淋巴细胞的主要趋化因子,尽管它也能引起人脐静脉内皮细胞(HUVECs)的迁移。我们使用单核细胞系THP-1、人外周血单核细胞和HUVECs来研究MCP-1受体介导的细胞迁移。我们发现,在存在p38丝裂原活化蛋白激酶(MAP-激酶)的特异性抑制剂时,THP-1和单核细胞的趋化性降低。此外,酪氨酸激酶抑制剂几乎完全消除了这种趋化性。相反,MCP-1刺激的HUVECs迁移被ERK1/2 MAP-激酶的特异性抑制剂消除,并且在较小程度上被阻断酪氨酸激酶所消除。这些结果表明,MCP-1在单核细胞和HUVECs中激活的细胞内信号通路是不同的。